| Dr Christopher James Brian Frandrup, MD | |
|
1400 S Potomac St Ste 150, Aurora, CO 80012-4541 | |
| (720) 307-7246 | |
| (720) 502-5271 |
| Full Name | Dr Christopher James Brian Frandrup |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 24 Years |
| Location | 1400 S Potomac St Ste 150, Aurora, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679563092 | NPI | - | NPPES |
| 72770121 | Other | CO | MEDICAID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | DR.006659 (Colorado) | Primary |
| 207L00000X | Anesthesiology | DR.006659 (Colorado) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allpria Healthcare Centers, Pc | 5193147999 | 3 |
News Archive
A cancer-suppressing gene has been successfully delivered into the tumors of stage 4 lung cancer patients via an intravenously administered lipid nanoparticle in a phase I clinical trial at The University of Texas M. D. Anderson Cancer Center.
Sequoia Capital Chairman Sir Michael Moritz, KBE, and his wife, Harriet Heyman, in collaboration with UC San Francisco, have kicked off a new endowment with a $60 million contribution to ensure the future of PhD education programs in the basic sciences.
Human Genome Sciences, Inc. announced today that it has begun dosing patients in a Phase 2 clinical trial of Albuferon™ (albumin-interferon alpha) in patients with chronic hepatitis C who are naïve to interferon-alpha treatments.
The brain is a "time machine," assert Duke neuroscientists Catalin Buhusi and Warren Meck. And understanding how the brain tracks time is essential to understanding all its functions. The brain's internal clocks coordinate a vast array of activities from communicating, to orchestrating movement, to getting food, they said.
Rolapitant reduces nausea and vomiting in patients receiving cisplatin-based chemotherapy, according to the results of a phase III trial presented for the first time today at the ESMO 2014 Congress in Madrid, Spain.
› Verified 8 days ago
| Entity Name | Allpria Enterprises |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164949855 PECOS PAC ID: 1254691579 Enrollment ID: O20180207000391 |
News Archive
A cancer-suppressing gene has been successfully delivered into the tumors of stage 4 lung cancer patients via an intravenously administered lipid nanoparticle in a phase I clinical trial at The University of Texas M. D. Anderson Cancer Center.
Sequoia Capital Chairman Sir Michael Moritz, KBE, and his wife, Harriet Heyman, in collaboration with UC San Francisco, have kicked off a new endowment with a $60 million contribution to ensure the future of PhD education programs in the basic sciences.
Human Genome Sciences, Inc. announced today that it has begun dosing patients in a Phase 2 clinical trial of Albuferon™ (albumin-interferon alpha) in patients with chronic hepatitis C who are naïve to interferon-alpha treatments.
The brain is a "time machine," assert Duke neuroscientists Catalin Buhusi and Warren Meck. And understanding how the brain tracks time is essential to understanding all its functions. The brain's internal clocks coordinate a vast array of activities from communicating, to orchestrating movement, to getting food, they said.
Rolapitant reduces nausea and vomiting in patients receiving cisplatin-based chemotherapy, according to the results of a phase III trial presented for the first time today at the ESMO 2014 Congress in Madrid, Spain.
› Verified 8 days ago
| Entity Name | Allpria Healthcare Centers, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164949855 PECOS PAC ID: 5193147999 Enrollment ID: O20200909002911 |
News Archive
A cancer-suppressing gene has been successfully delivered into the tumors of stage 4 lung cancer patients via an intravenously administered lipid nanoparticle in a phase I clinical trial at The University of Texas M. D. Anderson Cancer Center.
Sequoia Capital Chairman Sir Michael Moritz, KBE, and his wife, Harriet Heyman, in collaboration with UC San Francisco, have kicked off a new endowment with a $60 million contribution to ensure the future of PhD education programs in the basic sciences.
Human Genome Sciences, Inc. announced today that it has begun dosing patients in a Phase 2 clinical trial of Albuferon™ (albumin-interferon alpha) in patients with chronic hepatitis C who are naïve to interferon-alpha treatments.
The brain is a "time machine," assert Duke neuroscientists Catalin Buhusi and Warren Meck. And understanding how the brain tracks time is essential to understanding all its functions. The brain's internal clocks coordinate a vast array of activities from communicating, to orchestrating movement, to getting food, they said.
Rolapitant reduces nausea and vomiting in patients receiving cisplatin-based chemotherapy, according to the results of a phase III trial presented for the first time today at the ESMO 2014 Congress in Madrid, Spain.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher James Brian Frandrup, MD Po Box 370382, Denver, CO 80237-0382 Ph: (702) 307-7246 | Dr Christopher James Brian Frandrup, MD 1400 S Potomac St Ste 150, Aurora, CO 80012-4541 Ph: (720) 307-7246 |
News Archive
A cancer-suppressing gene has been successfully delivered into the tumors of stage 4 lung cancer patients via an intravenously administered lipid nanoparticle in a phase I clinical trial at The University of Texas M. D. Anderson Cancer Center.
Sequoia Capital Chairman Sir Michael Moritz, KBE, and his wife, Harriet Heyman, in collaboration with UC San Francisco, have kicked off a new endowment with a $60 million contribution to ensure the future of PhD education programs in the basic sciences.
Human Genome Sciences, Inc. announced today that it has begun dosing patients in a Phase 2 clinical trial of Albuferon™ (albumin-interferon alpha) in patients with chronic hepatitis C who are naïve to interferon-alpha treatments.
The brain is a "time machine," assert Duke neuroscientists Catalin Buhusi and Warren Meck. And understanding how the brain tracks time is essential to understanding all its functions. The brain's internal clocks coordinate a vast array of activities from communicating, to orchestrating movement, to getting food, they said.
Rolapitant reduces nausea and vomiting in patients receiving cisplatin-based chemotherapy, according to the results of a phase III trial presented for the first time today at the ESMO 2014 Congress in Madrid, Spain.
› Verified 8 days ago
Floyd O Ring, M.D. Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 900 Potomac St, Aurora, CO 80011 Phone: 303-363-5333 Fax: 303-363-5322 |